D-0171-2027 Class II Ongoing
FDA drug recall D-0171-2027 was initiated by Fresenius Medical Care Renal Therapies Group, LLC on Oct 14, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots. The recall status is ongoing. Affected quantity: 116 cases (5 bags per case).
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2026
- Initiation Date
- Oct 14, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 116 cases (5 bags per case)
Product description
Reason for recall
Distribution pattern
Nationwide in the USA.
Code information
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0171-2027
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Fresenius Medical Care Renal Therapies Group, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.